Ingles IMKTA Stock Trend Trade 123 20260420 MAZE Maze Therapeutics posts narrower Q4 2025 loss than expected shares drop 237 percent amid missing quarterly revenue figures MESHW Meshflow management shares potential merger timeline and market expansion goals in quarterly earnings ARDX Ardelyx reports 100 negative Q4 2025 EPS surprise as shares edge 017 lower today VCI Global VCIG Stock Consolidation Phase Insight VCI Global posts record EPS and revenue no prior estimates Amylyx Pharmaceuticals AMLX Sees Uptick Amid Key Resistance Test Biotech Stock Gains 285 Sonoma Pharmaceuticals SNOA Edges Higher Testing Key Resistance at 113 Freshpet Inc FRPT Edges Higher Amid Consolidation Near Key Resistance Levels Acrivon Therapeutics ACRV Narrows Lower as Biotech Sentiment Remains Cautious